Personalized and Precision Medicine International Conference – PEMED 2020

The right therapeutic/prevention strategy for the right person at the right time.

Whether you are interested in diagnostics, bioinformatics, drug discovery, and therapies, with the aim of translating precision medicine into direct improvements in health care, PEMED is the place to be. This annual Personalized and Precision Medicine International Conference gathers the best experts in the field to meet, discuss and eventually do business.

CHAIRS COMMITTEE

Prof. Ann K. Daly

University Medical School, United Kingdom

Prof. Matthias Schwab

IKP and Dept of Clinical Pharmacology,
Univ Hospital of Tuebingen, Germany

Prof. Anne-Marie Caminade

Coordination Chemistry Lab of Toulouse and University of Toulouse, France

SPECIAL GUESTS

Prof. William E. Evans

St. Jude Children’s Research Hospital, United States

Mary V. Relling

St. Jude Children’s Research Hospital, United States

PLENARY SPEAKERS

Prof. Volker Lauschke

Karolinska Institute, Stockholm, Sweden

Prof. Nikolaus Rajewsky

Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany

Prof. Elvira Bramon

University College London, UK

Prof. Karine Clément

Pitié-Salpêtrière hospital, Paris, France

Prof. Doug Easton

University of Cambridge, UK

Prof. Superti-Furga

CeMM Research Center for Molecular Medicine, Austria

Prof. Prof. Stefan Endres

University München, Clinical Pharmacology, Germany

Prof. Manel Esteller

Josep Carreras Leukaemia Research Institute (IJC), Spain

Prof. Henk-Jan Guchelaar

University of Leiden, The Netherlands

Prof. Muzlifah Haniffa

Newcastle University, UK

PD Dr. Ursula Amstutz

Universitätsinstitut für Klinische Chemie, Switzerland

Prof. Klaus Pantel

UKE University Medical Center Hamburg-Eppendorf, Germany

Dr. Jun J. Yang

St. Jude Children’s Research Hospital, Memphis, USA

Prof. Michael Zimmermann

EMBL Heidelberg, Germany

Dr. Mathias Wilhelm

Technical University of Munich, Germany

Prof. German Ott

Institut für klinische Pharmakologie IKP, Stuttgart, Germany

Prof. Thomas Lengauer

Max Planck Institute for Informatics (MPI-INF), Saarbrucken, Germany

Prof. Martin Hrabe de Angelis

Helmholtz Zentrum München, Munich, Germany

Prof. Ewan Pearson

Division of Public Health and Genomics, School of Medicine, University of Dundee, UK

Prof. Roland Eils

Berliner Institut für Gesundheitsforschung (BIG) BIH Zentrum für Digitale Gesundheit, Berlin, Germany

TOPICS
Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, etc.)
Biomarkers and diagnostics, liquid biopsy, imaging, biochip/microarray technologies, advancements in technologies
Drug target discovery and integration with individualized therapy, integration of diagnosis with therapy (theragnosis)
Integrating Big Data (genome data, pharmacogenomics, therapeutic applications of genome editing, genetic analysis in clinical trials methodology, etc.)
Emerging opportunities in personalized medicine, cutting-edge new strategies and solutions
Cost-benefit issues, and ethics in precision medicine

h

PUBLICATION

All accepted abstracts will be scheduled for oral, poster or workshop presentation and will be compiled in PDF format. A digital version of the book of abstracts will be available online.

Then, you will be able to publish your full papers (optional) in the renowned journal EPMA Journal.

EPMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). More information here

Research and review articles, as well as position papers, are published in a hydride-model: the authors decide between free of charge “subscription” model and “open access”.

Instructions for authors: http://www.springer.com/biomed/journal/13167

Additionally, The MDPI Open access Journal of Personalized Medicine will also offer you a special congress 20% discount on their publication fees, meet them at their booth for more information.